Basics VYNE Therapeutics Inc. IPO Date: January 22, 2018 Sector: Healthcare Market Cap: $7.62M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 4.17% Avg Daily Range (30 D): $0.02 | 3.62% Avg Daily Range (90 D): $0.06 | 5.19% Institutional Daily Volume Avg Daily Volume: .96M Avg Daily Volume (30 D): 2.93M Avg Daily Volume (90 D): 1.38M Trade Size Avg Trade Size (Sh.): 313 Avg Trade Size (Sh.) (30 D): 772 Avg Trade Size (Sh.) (90 D): 585 Institutional Trades Total Inst.Trades: 35 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $.55M Avg Inst. Trade (90 D): $.55M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.91M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 31.93K     News Aug 14, 2025 @ 5:00 PM Vitiligo Clinical Trial Pipeline Accelerates as 18... Source: Delveinsight Jun 26, 2024 @ 12:00 PM VYNE Therapeutics to Participate in Leerink Partne... Source: VYNE Therapeutics Inc. Jun 14, 2024 @ 1:01 PM Analyst Scoreboard: 4 Ratings For VYNE Therapeutic... Source: Benzinga Insights Jun 13, 2024 @ 1:02 PM VYNE Therapeutics Announces Dosing of First Partic... Source: VYNE Therapeutics Inc. May 9, 2024 @ 1:15 PM VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Mis... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.13 $-.2 $-.28 Diluted EPS $-.13 $-.2 $-.28 Revenue $ .07M $ .2M $ .08M Gross Profit $ $ $ Net Income / Loss $ -5.76M $ -8.61M $ -12.02M Operating Income / Loss $ -7.54M $ -9.2M $ -12.77M Cost of Revenue $ $ $ Net Cash Flow $ -6.16M $ 8.28M $ 3.61M PE Ratio     Splits Feb 13, 2023:   1:18 Feb 16, 2021:   1:4